Home »

Cocrystal Pharma, HitGen and InterX Enter into Drug Discovery Collaboration

ATLANTA, GA and BOTHELL, WA — (Marketwired) — 09/05/17 — Cocrystal Pharma, Inc. (OTCQB: COCP) today announced that it has entered into a research collaboration with HitGen, Ltd., a private biotechnology company and InterX, Inc., a private computer software company to develop small molecule drug candidates against several undisclosed targets.Through the collaboration, Cocrystal, HitGen and InterX scientists will apply HitGen–s DNA-encoded library (DEL) technology platform and research capabi

Analytics

© 2020 88Finance. All Rights Reserved. Log in - Copyright by LayerMedia


Blogverzeichnis - Blog Verzeichnis bloggerei.de Blog Top Liste - by TopBlogs.de